Pharmacolog i Uppsala AB (publ) EBIT

As of the most recent data (March 2024), PHLOG-B.ST shows a EBIT of $-14M. That compares with $-19M in the prior-year period — up 25.1% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHLOG-B.ST's EBIT is now $-14M (was $-19M) — a 25.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pharmacolog i Uppsala AB (publ) is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. Pharmacolog i Uppsala AB (publ) is at $-14M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PHLOG-B.ST stacks up against individual peers as well.

Tracking PHLOG-B.ST's ebit over time shows whether Pharmacolog i Uppsala AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $-14M That compares with $-19M in the prior-year period — up 25.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Pharmacolog i Uppsala AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-14M) with ownership activity and broader fundamentals.